Search

Your search keyword '"Aguiar, Renato S."' showing total 163 results

Search Constraints

Start Over You searched for: Author "Aguiar, Renato S." Remove constraint Author: "Aguiar, Renato S."
163 results on '"Aguiar, Renato S."'

Search Results

1. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

2. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

3. Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications

4. High SARS-CoV-2 tropism and activation of immune cells in the testes of non-vaccinated deceased COVID-19 patients

5. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

6. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

7. Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals

8. Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

10. Author Correction: Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals

12. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

13. Changes in neurodegeneration and amyloid biomarkers in patients with COVID-19 neurological complications and Alzheimer’s disease

14. Clinical antiviral efficacy of remdesivir in COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)

16. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial

18. The Omicron Lineages BA.1 and BA.2 (Betacoronavirus SARS-CoV-2) Have Repeatedly Entered Brazil through a Single Dispersal Hub

19. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study

20. Impact of Early Pandemic SARS-CoV-2 Lineages Replacement with the Variant of Concern P.1 (Gamma) in Western Bahia, Brazil

21. Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants

22. The spectrum of neuropathological changes associated with congenital Zika virus infection

23. Tracking the turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian state (Minas Gerais) with a high-vaccination status

24. Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program

26. SARS-CoV-2 infects, replicates, elevates angiotensin II and activates immune cells in human testes

28. Report 46: Factors driving extensive spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals

29. Intra-host evolution during SARS-CoV-2 prolonged infection

30. Usefulness of microsatellite typing in population genetic studies of Trypanosoma cruzi

31. Whole-exome sequencing reveals insights into genetic susceptibility to Congenital Zika Syndrome

32. Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil

33. Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil

34. Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans

35. Genomic Surveillance of Yellow Fever Virus Epizootic in São Paulo, Brazil, 2016 – 2018

36. Genomic Surveillance of Yellow Fever Virus Epizootic in São Paulo, Brazil, 2016 – 2018

37. Evolution and epidemic spread of SARS-CoV-2 in Brazil

38. Outcomes of subsequent pregnancies following Zika virus infection: A comparative case series

39. Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome

40. Supplemental Material1 - Supplemental material for MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection

41. The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders

42. The potential role of collagens in congenital Zika syndrome: A systems biology approach

43. MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection

44. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1

45. Detection of sexually transmitted infections at a Brazilian gynecology center: high prevalence of co-infections

46. Zika Virus Infects, Activates, and Crosses Brain Microvascular Endothelial Cells, without Barrier Disruption

47. Zika virus disrupts molecular fingerprinting of human neurospheres

49. The Impact of African and Brazilian Zika virus isolates on neuroprogenitors

50. TLR-2 and TLR-4 agonists favor expansion of CD4+T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders

Catalog

Books, media, physical & digital resources